Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA, WHO, and other public sources. It is an independent information service, not a medical provider, and not a substitute for professional medical advice or your local public health department's own guidance.
Please review the following before continuing:
Policy version 2026-07-21, effective July 21, 2026.
United States
TerminatedClass III
Product may contain Metronidazole
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| NOW Bee Pollen 500mg 100 VCAPS UPC 733739025203 | 733739025203 | 33,056 units | Lots: 3209226 3184250 |
This recall shares FDA event ID 88769 with 2 other product entries in Public Health Trace.
FDA Recall United States TerminatedTerminated: August 12, 2024Historical recordClass III
FDA Recall United States TerminatedTerminated: August 12, 2024Historical recordClass III
Responsible company: NOW Health Group Inc.
FDA Recall United States TerminatedTerminated: August 12, 2024Historical recordClass III
FDA Recall United States TerminatedTerminated: August 12, 2024Historical recordClass III
FDA Recall United States TerminatedTerminated: January 23, 2023Historical recordClass III
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| Alaska | 1 |
| Alabama | 1 |
| Arkansas | 1 |
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Delaware | 1 |
| Florida | 1 |
| Georgia | 1 |
| Iowa | 1 |
| Idaho | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Kentucky | 1 |
| Louisiana | 1 |
| Massachusetts | 1 |
| Maryland | 1 |
| Maine | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| Mississippi | 1 |
| Montana | 1 |
| North Carolina | 1 |
| North Dakota | 1 |
| Nebraska | 1 |
| New Hampshire | 1 |
| New Jersey | 1 |
| New Mexico | 1 |
| Nevada | 1 |
| New York | 1 |
| Ohio | 1 |
| Oklahoma | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
| South Carolina | 1 |
| South Dakota | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Utah | 1 |
| Virginia | 1 |
| Vermont | 1 |
| Washington | 1 |
| Wisconsin | 1 |
| Wyoming | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
A situation in which use of or exposure to a product is not likely to cause adverse health consequences.
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
Reconnecting to the server…
We lost the connection to the server.
Your session has expired.
